Protocol · PharmD · Delaware
Practice Protocol for Pharmacists in Delaware
Required. Delaware law names the instrument a Collaborative Pharmacy Practice Agreement, and the clinical protocol is the content that instrument carries. Below: the board that governs it, what it must contain, and the terms it has to carry.
Represents Delaware's 'Collaborative Pharmacy Practice' tier (enacted 2023, Delaware the 50th state to authorize it), not ordinary licensure — base dispensing needs no agreement and is out of scope here. No independence pathway away from the collaborative pharmacy practice agreement (CPPA) was found.
What a Delaware Collaborative Pharmacy Practice Agreement must contain
Governed by the Delaware Board of Pharmacy. Each numbered item is a statutory requirement the Collaborative Pharmacy Practice Agreement must satisfy.
The Pharmacist may provide patient care and drug therapy management services not otherwise permitted to a pharmacist by general licensure only pursuant to a written and signed collaborative pharmacy practice agreement with the Physician, as defined by 24 Del. C. § 2502. The agreement shall define the nature, scope, conditions, and limitations of the services the Pharmacist may provide.
Source: 24 Del. C. § 2502
Delaware law does not require a pharmacist to enter into a collaborative pharmacy practice agreement in order to hold a pharmacist license or dispense medications generally; the agreement described in this Agreement is required only for the expanded patient care and drug therapy management services described above.
- The Collaborative Pharmacy Practice Agreement also carries 1 registration clauses, authored in the document itself.
Statutes and rules these clauses cite
- 24 Del. C. § 2502statute
Defines 'collaborative pharmacy practice' and 'collaborative pharmacy practice agreement.'
Terms it has to carry
Ratio, proximity, chart review, meeting and prescribing terms the Collaborative Pharmacy Practice Agreement has to carry, from Delaware's supervision rules.
Proximity
Not codified — left to the agreement
Supervision ratio
Not codified — no cap on file
Chart review
Not codified — left to the agreement
Meeting cadence
Not codified — left to the agreement
Prescriptive authority
Covered by the practice agreement · controlled substances permitted
The collaborative pharmacy practice agreement defines the nature, scope, conditions and limitations of the drug-therapy-management services the pharmacist may provide. Whether controlled substances are schedule-restricted within that scope is not settled by the statute.
Written agreement
Required
Practice ownership (corporate practice of medicine)
Non-licensee ownership permitted — A pharmacy permit may be held by a non-pharmacist/artificial entity only if a majority of the pharmacy is owned by licensed pharmacists; existing permit holders and hospital pharmacies are grandfathered/exempted from the requirement (24 Del.C. Title 24 Ch. 25, Subch. IV).
Materially more permissive than the nursing/PA professional-corporation regime above, but not unrestricted — a pharmacist-majority stake is required for new permits.
Sources for the supervision rules (2)
About Delaware's rules
Delaware grants full independent practice to APRNs (NP, CRNA, CNM, CNS) after a uniform 2-year, 4,000-hour transition period (24 Del.C. § 1906(20); 24 DE Admin. Code 1900 § 8.0). This entry applies that rule identically across the four APRN roles; confirm role-specific detail with the Board of Nursing. PAs have no independent-practice pathway.
Other clinicians in Delaware: see the state overview.